Linh Hoang

Linh Hoang

About

Detail

Chief Executive Officer
United States

Timeline


work
Job
school
Education
auto_stories
Publication

Résumé


Jobs verified_user 0% verified
  • HistoWiz
    Chief Executive Officer
    HistoWiz
    Oct 2022 - Current (3 years 9 months)
    HistoWiz automates histopathology with rapid turnaround times for researchers in academia, biotech and pharma. The company utilizes state-of-the-art technologies to process tissue specimens and host the digitized results on a proprietary platform, PathologyMapTM. Researchers use this advanced, online platform to manage their histology data and to collaborate with researchers across the world. With HistoWiz’s AI and proprietary tools, PathologyMap bridges researchers to a network of top pathologists for on-demand interpretation with industry-leading turnaround times. HistoWiz aims to become the global leader in histopathology to accelerate research and discovery.
  • Weavr Health
    Chief Executive Officer and Chairman of the Board
    Weavr Health
    May 2020 - Sep 2022 (2 years 5 months)
    Weavr Health develops simple and intuitive blood collection devices designed to greatly simplify and revolutionize blood testing globally. We aim to replace phlebotomy and still enable labs to use existing testing platforms. Our mission is to design devices and software that make it easier for people, and their healthcare providers, to connect to their health. We have recently launched with LabCorp and Nightingale.
  • PerkinElmer
    VP/GM Reproductive Health Diagnostics
    PerkinElmer
    Aug 2017 - May 2020 (2 years 10 months)
    Prenatal and Neonatal screening businesses
  • PerkinElmer Inc
    VP/GM Neonatal Screening Diagnostics
    PerkinElmer Inc
    Nov 2015 - Aug 2017 (1 year 10 months)
  • Thermo Fisher Scientific
    Senior Director of Clinical QC Product Line
    Thermo Fisher Scientific
    Feb 2014 - Oct 2015 (1 year 9 months)
  • Thermo Fisher Scientific
    Head of Inherited Diseases and General Manager of AcroMetrix
    Thermo Fisher Scientific
    Apr 2012 - Feb 2014 (1 year 11 months)
  • Thermo Fisher Scientific
    General Manager of AcroMetrix - part of Thermo
    Thermo Fisher Scientific
    Jan 2011 - Apr 2012 (1 year 4 months)
  • Thermo Fisher Scientific
    Director of Personalized Medicine
    Thermo Fisher Scientific
    Jan 2009 - Dec 2011 (3 years)
  • Thermo Fisher Scientific
    Director of BioProduction
    Thermo Fisher Scientific
    Jan 2006 - Dec 2009 (4 years)
  • Boston Consulting Group BCG
    Consultant
    Boston Consulting Group BCG
    Jan 2004 - Dec 2006 (3 years)
Education verified_user 0% verified
  • University of Pennsylvania
    MD, PhD, Medicine, BioPhysics
    University of Pennsylvania
    Jan 1996 - Dec 2004 (9 years)
  • University of Florida
    BS, Biochemistry
    University of Florida
    Jan 1992 - Dec 1996 (5 years)
  • E
    International Baccalaureate Diploma
    Eastside
    Jan 1988 - Dec 1992 (5 years)
Publications verified_user 0% verified
  • M
    Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnera
    Mol Cancer Ther
    Jan 2013
    Triple-negative breast cancer (TNBC) is characterized by the absence of expression of estrogen receptor, progesterone receptor, and HER-2. Thirty percent of patients recur after first-line treatment, and metastatic TNBC (mTNBC) has a poor prognosis with median survival of one year. Here, we present initial analyses of whole genome and transcriptome sequencing data from 14 prospective mTNBC. We have cataloged the collection of somatic genomic alterations in these advanced tumors, particularly those that may inform targeted therapies. Genes mutated in multiple tumors included TP53, LRP1B, HERC1, CDH5, RB1, and NF1. Notable genes involved in focal structural events were CTNNA1, PTEN, FBXW7, BRCA2, WT1, FGFR1, KRAS, HRAS, ARAF, BRAF, and PGCP.
  • S
    Whole-genome sequencing for optimized patient management.
    Science Translational Medicine
    Jun 2011
    Whole-genome sequencing of patient DNA can facilitate diagnosis of a disease, but its potential for guiding treatment has been under-realized. We interrogated the complete genome sequences of a 14-year-old fraternal twin pair diagnosed with dopa (3,4-dihydroxyphenylalanine)-responsive dystonia (DRD; Mendelian Inheritance in Man #128230). DRD is a genetically heterogeneous and clinically complex movement disorder that is usually treated with l-dopa, a precursor of the neurotransmitter dopamine. Whole-genome sequencing identified compound heterozygous mutations in the SPR gene encoding sepiapterin reductase. Disruption of SPR causes a decrease in tetrahydrobiopterin, a cofactor required for the hydroxylase enzymes that synthesize the neurotra
  • PNAS
    Cytochrome c folding pathway: Kinetic native-state hydrogen exchange
    PNAS
    Sep 2002
    Native-state hydrogen exchange experiments under EX1 conditions can distinguish partially unfolded intermediates by their formation rates and identify the amide hydrogens exposed and protected in each. Results obtained define a cytochrome c intermediate seen only poorly before and place it early on the major unfolding pathway. Four distinct unfolding steps are found to be kinetically ordered in the same pathway sequence inferred before.
  • PNAS
    Water magnetic relaxation dispersion in biological systems: the contribution of proton exchange and implications for the
    PNAS
    Oct 2001
    Magnetic relaxation has been used extensively to study and characterize biological tissues. In particular, spin-lattice relaxation in the rotating frame (T1ρ) of water in protein solutions has been demonstrated to be sensitive to macromolecular weight and composition. However, the nature of the contribution from low frequency processes to water relaxation remains unclear. We have examined this problem by studying the water T1ρ dispersion in peptide solutions (14N- and 15N-labeled), glycosaminoglycan solutions, and samples of bovine articular cartilage before and after proteoglycan degradation. We find in model systems and tissue that hydrogen exchange from NH and OH groups to water dominates the low frequency water T1ρ dispersion, in the co
  • PNAS
    An amino acid code for protein folding
    PNAS
    Jan 2001
    Direct structural information obtained for many proteins supports the following conclusions. The amino acid sequences of proteins can stabilize not only the final native state but also a small set of discrete partially folded native-like intermediates. Intermediates are formed in steps that use as units the cooperative secondary structural elements of the native protein. Earlier intermediates guide the addition of subsequent units in a process of sequential stabilization mediated by native-like tertiary interactions. The resulting stepwise self-assembly process automatically constructs a folding pathway, whether linear or branched. These conclusions are drawn mainly from hydrogen exchange-based methods, which can depict the structure of inf
This is a community-created genome.